Business Name: |
Keyser Jeffrey A DO |
Contact Person: |
Jeffrey Keyser |
Address: |
804 Grandview Drive # 1, Ephrata, Pennsylvania 17522 |
Phone Number: |
(717) 733-2251 |
Website Address: |
lancastercountypodiatry.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Jarowenko Mark V MD - Ephrata, PA 17522 Groleau George E MD - Ephrata, PA 17522 Gallagher Stephanie M DO - Ephrata, PA 17522 Conrad Wayne R MD - Ephrata, PA 17522 Martin Joanne MD - Ephrata, PA 17522 Battaile Melinda J MD - Ephrata, PA 17522 Aversa Jeffrey M MD - Ephrata, PA 17522 O'Connor Thomas M DO - Ephrata, PA 17522 Hric Jerome J MD - Ephrata, PA 17522 Dahlgren Andrew B MD - Ephrata, PA 17522 Buchh Basharat N MD - Ephrata, PA 17522 Lyet J Paul MD - Ephrata, PA 17522 Fasulo Gregg J MD - Ephrata, PA 17522 Weber Jeffrey K MD - Ephrata, PA 17522 Tuckman Alan S MD - Ephrata, PA 17522 Tymon Timothy P MD - Ephrata, PA 17522 Keener Brian J MD - Ephrata, PA 17522 Porter John MD - Ephrata, PA 17522 Hager Christopher MD - Ephrata, PA 17522 Worrell Lindsay A MD - Ephrata, PA 17522 |
The company Keyser Jeffrey A DO provides B2C services in the form of Doctors from its single location in Pennsylvania.
1 to 4 employees work for Keyser Jeffrey A DO, and the business now earns $500.000 to $999.999 per annum.
Keyser Jeffrey A DO was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Keyser Jeffrey A DO, please call Jeffrey Keyser with the phone number (717) 733-2251 or visit its single location at 804 Grandview Drive # 1 in Ephrata, Pennsylvania 17522.
The location of the single location can also be found using the coordinates 40.18927,-76.1826.
Read more details about this business on the webpage lancastercountypodiatry.com or follow the company’s social media accounts, on Twitter and on Facebook.